Gf Fund Management Co. Ltd. Edgewise Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,424 shares of EWTX stock, worth $34,493. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,424
Previous 1,988
21.93%
Holding current value
$34,493
Previous $53.1 Million
0.47%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$214 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$127 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$93.2 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$87.6 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$85.6 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $899M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...